Skip to content
The Nexus
DossierENTITY

AI drug discovery CEO

Coverage of AI drug discovery CEO in the Nexus archive.

Earliest in view: May 26 · 13:50 UTCMost recent: May 26 · 13:50 UTC
Co-mentioned in this coverage
Eli Lillyorganization1interim FDA chiefperson1gene-editingtopic1high cholesteroltopic1FDAorganization1
Recent coverage
  • HEALTHMay 26 · 13:50 UTCSTAT NEWS
    STAT+: Five biotech news updates to stay on top of today

    Eli Lilly’s gene-editing data shows promise for treating high cholesterol, an AI drug discovery CEO addressed industry hype, and the new interim FDA chief has received positive initial reactions. The article highlights key biotech developments impacting science and regulatory landscapes.